NRC
NRC Health
Set alert
- YTD
- +26.96%
- 1 year
- +81.91%
- Open
- 23.64
- Prev close
- 23.49
- Mkt cap
- 505.71M
- Vol
- 86.22K
- Avg vol
- 116.50K
- EPS
- 0.27
- P/E
- 88.26
- Div yield
- 2.80%
More statistics
- Low
- 23.47
- High
- 24.01
- Forward P/E
- 15.38
- Beta
- 0.53
- Short ratio
- 4.02
- Inst. own
- 52.02%
- Dividend
- 0.48
- Ex-div date
- Dec 26, 2024
- Earnings
- Feb 11, 2025
- 50-d avg
- 18.96
- 200-d avg
- 25.47
- 1y target
- 0.00
Key statistics
- Market cap
- 418.81M
- Enterprise value
- 453.93M
- Trailing P/E
- 15.93
- Forward P/E
- 15.38
- PEG ratio
- 0.00
- Price / sales
- 2.91
- Price / book
- 12.09
- EPS (TTM)
- 1.12
- Beta
- 0.53
- Dividend yield
- 2.80%
- Payout ratio
- 42.86%
- Profit margin
- 18.79%
- Revenue (TTM)
- 144.16M
- Revenue growth
- -5.60%
- Free cash flow
- 21.74M
- Total cash
- 3.46M
- Total debt
- 54.30M
- Return on equity
- 58.56%
- Shares outstanding
- 23.48M
- Short % of float
- 2.95%
- 50-day average
- 18.96
- 200-day average
- 25.47
Analyst view
Consensus: none
Next earnings
Feb 11, 2025
Expected Feb 11, 2025. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2025 | Dec 1, 2024 | 0.00 | — | — | — |
| Oct 25, 2024 | Sep 1, 2024 | 0.00 | 0.24 | — | — |
| Aug 6, 2024 | Jun 1, 2024 | 0.00 | 0.26 | — | — |
| May 7, 2024 | Mar 1, 2024 | 0.00 | 0.27 | — | — |
| Feb 13, 2024 | Dec 1, 2023 | 0.00 | 0.36 | — | — |
| Nov 7, 2023 | Sep 1, 2023 | 0.00 | 0.32 | — | — |
About NRC Health
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- nrchealth.com
News
- NRC Completes Landmark Safety Review of X-energy's Xe-100 SMR
- RETRANSMISSION: Manganese X Energy Provides Battery Hill High-Purity Manganese Sample for NRC-Led POSCO LMR Cathode Research Project
- Manganese X Energy Provides Battery Hill High-Purity Manganese Sample for NRC-Led POSCO LMR Cathode Research Project
- Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $27
- National Research Q3 Earnings Call Highlights
- National Research Q3 2026 Earnings Call Transcript
- National Research Q3 Adj. EPS $0.21, Inline, Sales $38.399M Beat $35.800M Estimate
- NRC Health Announces Third Quarter 2026 Results
- NRC Health Launches nQuire Pro, Extending the Reach of Patient-Experience Teams
- NuScale Power Trades Below $6 With the Only NRC-Certified Small Modular Reactor Design. Here's Why That Still Isn't Enough.
Your note
Sign in to keep a note on NRC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AMANDLA MK TRUST | Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 4, 2024 | 0 |
| COMMON PROPERTY TRUST | Beneficial Owner of more than 10% of a Class of Security | Sale | Feb 29, 2024 | 0 |
| HAYS MICHAEL D | Chief Executive Officer | Conversion of Exercise of derivative security | Jan 1, 2024 | 77,090 |
| KARAS KEVIN R | Chief Financial Officer | Sale | Feb 27, 2023 | 5,384 |
| NUNNELLY JOHN N | Director | Conversion of Exercise of derivative security | Mar 26, 2024 | 32,666 |
| RAASCH JONA S | Officer | Sale | Apr 2, 2023 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 13.03% | 3,059,576 | 54.58M | Sep 29, 2024 |
| Blackrock Inc. | 4.96% | 1,164,256 | 20.77M | Sep 29, 2024 |
| Vanguard Group Inc | 4.20% | 986,370 | 17.60M | Sep 29, 2024 |
| Morgan Stanley | 3.91% | 918,757 | 16.39M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 2.52% | 590,797 | 10.54M | Sep 29, 2024 |
| Geode Capital Management, LLC | 1.79% | 420,733 | 7.51M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Virtus Equity Tr-Virtus KAR Small Cap Growth Fd | 8.55% | 2,008,009 | 35.82M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 2.51% | 589,022 | 10.51M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.58% | 371,657 | 6.63M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.04% | 243,529 | 4.34M | Sep 29, 2024 |
| DFA U.S. Micro Cap Series | 0.95% | 222,620 | 3.97M | Jul 30, 2024 |
| Fidelity Small Cap Index Fund | 0.66% | 155,361 | 2.77M | Aug 30, 2024 |